Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605045 · ClinicalTrials.gov registry record · Phase 4
Screening for Coronary Artery Disease Using Fluoroscopy During Coronary Angiography
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01605045: Completed Phase 4 study, sponsored by NYU Langone Health.
NCT01605045 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01605045, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the effects of screening using the fluoroscopy-save function on reduction of radiation exposure and quality of angiogram during cardiac catheterization when compared to traditional cinematography-guided coronary angiography.
Primary Outcome
Surface peak skin dose, as measured by the Gafchromic XR RV3 film strip, which is placed under the patient's back during the procedure.
Interventions
- OTHER Fluoroscopy-save group
- OTHER Standard technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-09 |
| Phase | Phase 4 |
What the finished NCT01605045 record still lists
NCT01605045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Fluoroscopy-save group is the first listed.
NCT01605045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01605045 about?
NCT01605045 is a clinical study titled "Screening for Coronary Artery Disease Using Fluoroscopy During Coronary Angiography". The aim of this study is to evaluate the effects of screening using the fluoroscopy-save function on reduction of radiation exposure and quality of angiogram during cardiac catheterization when compared to traditional cinematography-guided coronary angiography.
What is the current status of trial NCT01605045?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01605045?
The interventions under investigation include: Fluoroscopy-save group (OTHER), Standard technique (OTHER).
Who is sponsoring clinical trial NCT01605045?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01605045's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia